Recruiting Management of Immune Checkpoint Inhibition-related Hepatitis Using Low-dose Corticosteroids NCT07167251 Conditions Cancer, Immune Related Adverse Events, Immune-mediated Hepatitis, +1 more Locations University Hospital Basel — Basel, Canton of Basel-City, Switzerland Royal Marsden Hospital — London, United Kingdom View Trial Details
Recruiting Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository NCT06789601 Conditions Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Immune Related Adverse Events, +2 more Locations Brigham and Women's Hospital — Boston, Massachusetts, United States Dana-Farber Cancer Institute — Boston, Massachusetts, United States View Trial Details
Recruiting Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Sintilimab in Clinical Practice Among Chinese Patients NCT04840355 Conditions Immune Related Adverse Events, PD-1 Locations Cancer Hospital Chinese Academy of Medical Sciences — Beijing, Beijing Municipality, China View Trial Details
Completed ECP for Immune-related Adverse Events After Checkpoint Inhibitor Treatment NCT05414552 Conditions Colitis, Colonic Diseases, Dermatitis, +9 more Locations Medical Center - University of Freiburg Albert-Ludwigs-University Freiburg Department of Medicine I — Freiburg im Breisgau, Baden-Wurttemberg, Germany View Trial Details
